VIVOCEF-LB

Faster Recovery. Stronger Protection. Restored Gut Balance.

10x10 Tablets

Pharma

Antibacterial

Product highlights

Broad-spectrum antibacterial activity against Gram +ve & Gram – veorganisms
Effective against β-lactamase producing strains
Lower MIC → Higher potency vs common pathogens
Added probiotic support for gut flora restoration
Reduced risk of antibiotic-associated diarrhea
Longer half-life → Improved dosing convenience & compliance
Demonstrates superior pharmacodynamic profile vs other oral cephalosporins
Comparable or better efficacy than cefuroxime & cefpodoxime
Replenishes & Protects Normal Gut Flora During Antibiotic Therapy

VIVOCEF-LB is a combination antibiotic formulation containing Cefixime 200mg (a third-generation oral cephalosporin) and Lactic acid Bacillus 60MS (a probiotic). This unique combination provides potent broad-spectrum antibacterial coverage while simultaneously protecting and restoring the gut microbiome disrupted during antibiotic therapy, ensuring faster recovery and improved patient compliance.

Dosage Form

Film-coated Tablets (Oral)

Product Name

Composition

Cefixime 200mg + Lactic acid Bacillus 60MS per Tablet

Therapeutic Segment

Anti-infectives / Third-Generation Cephalosporins + Probiotics

Pharmacological Action

Cefixime is a bactericidal, broad-spectrum oral cephalosporin antibiotic. Lactic acid Bacillus is a probiotic that replenishes and maintains healthy gut flora.

Mechanism

Cefixime inhibits bacterial cell wall synthesis by binding to Penicillin Binding Proteins (PBPs), leading to cell lysis and bacterial death. It is stable against many β-lactamases. Lactic acid Bacillus colonises the gut, restores normal flora, and competitively inhibits pathogenic organisms.

Key Clinical Benefits

Potent bactericidal action against a wide range of Gram +ve and Gram –ve pathogens
Stable against β-lactamase enzymes — effective even against resistant strains
Lower MIC values ensure higher potency against common pathogens
Longer half-life allows once or twice daily dosing for better compliance
Superior pharmacodynamic profile over other oral cephalosporins
Probiotic component reduces antibiotic-associated diarrhea and GI side effects
Restores and protects gut microbiome during and after antibiotic therapy

Key Indications

Urinary Tract Infections (UTI)
Respiratory Tract Infections (RTI)
Skin & Soft Tissue Infections
Bone & Joint Infections
Typhoid Fever
Pharyngitis & Tonsillitis
Otitis Media

Administration

Oral — taken with or without food. Swallow whole with water.

Recommended Usage

Adults & Children >12 years: Cefixime 200mg – 400mg per day in 1–2 divided doses. Duration: 7–14 days or as directed by the physician. (Dosage may be adjusted based on severity of infection and clinical response.)

Dosage Form

Film-coated Tablets (Oral)

Product Name

Composition

Cefixime 200mg + Lactic acid Bacillus 60MS per Tablet

Therapeutic Segment

Anti-infectives / Third-Generation Cephalosporins + Probiotics

Pharmacological Action

Anti-infectives / Third-Generation Cephalosporins + Probiotics

Mechanism

Key Clinical Benefits

Potent bactericidal action against a wide range of Gram +ve and Gram –ve pathogens
Stable against β-lactamase enzymes — effective even against resistant strains
Lower MIC values ensure higher potency against common pathogens
Longer half-life allows once or twice daily dosing for better compliance
Superior pharmacodynamic profile over other oral cephalosporins
Probiotic component reduces antibiotic-associated diarrhea and GI side effects
Restores and protects gut microbiome during and after antibiotic therapy

Key Indications